CD4 and Merkel cell skin cancer: Phenotypic analysis of human CD3+ T cells from the MCC iPDX xenografts identified both CD4+ T cell (31.1 ± 21%) and CD8+ T cell (52.6 ± 12.6%) populations (Fig 3C).